Alector

The summer months often mean high temperatures, humidity and lots of strong sun. Excessive heat exposure can be dangerous, especially for people with conditions like #Alzheimers or #FTD. Read on for activities to help keep your loved one engaged while beating the heat this summer in part two of our Summer Break Series.

Meet VP of Financial Planning and Portfolio Valuation, Jason Banks! Jason describes Alector's work environment as full of people that are "very approachable and willing to help, no matter the role." Learn more about Jason below.

Congratulations to Alector President and Head of R&D Sara Kenkare-Mitra PhD on being named to San Francisco Business Times' Most Influential Women in Bay Area Business! Dr. Kenkare-Mitra has dedicated her career to developing novel medicines and personalizing treatments for patients. Her expertise has been integral to the advancement of our clinical and early-stage neurodegeneration programs. Congratulations, Dr. Kenkare-Mitra!

We are proud sponsors of next weekend's Crusade for a Cure golf tournament and benefit concert! Proceeds benefit the The Association for Frontotemporal Degeneration (AFTD)'s research initiatives. Find more details about this event here. https://lnkd.in/eCKbTtuH

Summer travel can pose unique challenges for those impacted by #dementia, but it doesn't have to stop you and your family from enjoying quality time together. In part one of our Summer Break Series, we're sharing some tips for navigating summer vacations with someone with dementia, from travel logistics to dementia-friendly activities. Click through below for more.

#DidYouKnow 1 in 5 Bay Area children live in poverty, despite it being ranked one of the world's most affluent areas? This summer, we are thrilled to support Family Giving Tree's annual Back-to-School Drive again. This year, Alector sponsored 76 backpacks with school supplies and raised over $3,500 for local students in need. Learn more about this important program here. https://lnkd.in/gxDGjvtm

Chief Business Officer Neil Berkley joined Alector this past spring bringing 20+ years of experience in business development, corporate development and strategic planning from pharma and biotech companies of all sizes to the team. Listen below as Neil shares more about Alector's unique value within the industry, and what he sees as the company's critical success factors in the coming years.

It has been an incredible week gathering with some of the best and brightest minds in #dementia research here in Philadelphia at #AAIC24. Our team is grateful for the opportunity to present data related to our pipeline programs, network with peers, and explore advancements in the neurodegeneration space. Thank you to the Alzheimer's Association® for a great conference!

We are pleased to announce the poster presentation on the baseline characteristics for the global INVOKE-2 Phase 2 clinical trial evaluating the safety and efficacy of our novel TREM2 agonist in slowing disease progression in individuals with early #Alzheimers disease at #AAIC24. Read more: https://lnkd.in/e9uGy6rF

“Everyone is very supportive and collaborative. It is great working with so many teams who all share the same passions," says Associate Scientist Rebecca Wang. She shares more about her commitment to Alector's mission of improving the lives of people with neurodegenerative diseases in this month's employee spotlight.